ARCHIVES

NCI Plans Trials of Burzynski’s ‘Antineoplaston’; JAMA Report Says No Antitumor Activity In Tests

This article is from The Cancer Letter archive.

Vol. 18 No. 23 | June 5, 1992

Download PDF Visit The Full Archive

Related Articles

In Brief : Patricia LoRusso Named Associate Director Of Innovative Medicine at Yale Cancer Center

June 20, 2014

Tobacco Council Grants Total 3,348

July 15, 1988

DeVita, Greenwald Assure Centers They’ll Get More Money for Cancer Control

May 11, 1984

FA Drug Approval on Activity, Rather Than Survival Urged By NCU

January 13, 1989

Tarceva-Induced Rash Strongly Associated With Longer Survival, Sponsor Finds

July 27, 2007

SOCMA Asks Congress for Carcinogen Classification Probe

March 25, 1988